• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Limoneira Announces Appointment of Elizabeth Mora to Board of Directors

    10/27/21 8:30:00 AM ET
    $INGN
    $LMNR
    $MKSI
    Industrial Specialties
    Health Care
    Farming/Seeds/Milling
    Consumer Staples
    Get the next $INGN alert in real time by email

    Seasoned Corporate Environmental Social and Governance ("ESG") Professional

    Limoneira Company (the "Company" or "Limoneira") (NASDAQ:LMNR), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, today announced the appointment of Elizabeth (Beth) Mora to the Company's Board of Directors. Following the appointment of Ms. Mora, the Board will be comprised of 11 directors, nine of whom are independent.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211027005021/en/

    Elizabeth Mora (Photo: Business Wire)

    Elizabeth Mora (Photo: Business Wire)

    Limoneira Chairman of the Board, Gordon Kimball, stated, "We are thrilled to welcome Ms. Mora to our board and believe her 30+ years of expansive industry experience, financial acumen and ESG expertise, will be a valuable addition to Limoneira. Ms. Mora is known as a strategic thought leader and a champion for diversity and inclusion and her guidance and leadership will be instrumental as we continue to evolve as a company."

    Ms. Mora is a seasoned board director, financial expert, and business operations executive, who built her career in the accounting, education and technology and research industries. Ms. Mora's more than 30-year career began at PricewaterhouseCoopers and her most recent role was as Chief Administrative Officer, Vice President for Finance, Administration and Treasurer at the Charles Stark Draper Laboratory, Inc. (Draper), a position she held from 2008 to 2020. Previously, Ms. Mora served in a variety of executive management roles at Harvard University from 1997 to 2008, including as Chief Financial Officer and Vice President for Finance and Associate Vice President, Research Administration. Ms. Mora currently serves as a board member for Inogen Inc. (NASDAQ:INGN), a medical technology company; MKS Instruments (NASDAQ:MKSI), a global semi-conductor equipment, laser, and laser packaging company; and Belay Associates, Everest Consolidator LLC, a private equity firm. Ms. Mora is a Certified Public Accountant and holds a Bachelor of Arts from the University of California, Berkeley, and a Master of Business Administration from Simmons College.

    During Ms. Mora's tenure as Chief Administrative Officer at Draper, she was instrumental in expanding the percentage of women and underrepresented minority employees from 10% to 25% of the employee base in six years. In addition, she ensured Draper was a strong supporter of the "Community Compact for a Sustainable Future" signed by Cambridge, Massachusetts, Harvard University and the Massachusetts Institute of Technology. Cambridge was the first city in the US to adopt sustainability guidelines for non-profits and businesses located in the city. Ms. Mora and her wife reside in the Boston area.

    "I am excited to be joining Limoneira's Board of Directors and working with a company that has such deep business and community roots spanning over a century. Together, I believe we will position Limoneira for another 100 years of sustainable growth, while still honoring its legacy and expanding on the Company's history of sustainable farming and business practices."

    About Limoneira Company

    Limoneira Company, a 128-year-old international agribusiness headquartered in Santa Paula, California, has grown to become one of the premier integrated agribusinesses in the world. Limoneira (lç moñ âra) is a dedicated sustainability company with 15,400 acres of rich agricultural lands, real estate properties, and water rights in California, Arizona, Chile and Argentina. The Company is a leading producer of lemons, avocados, oranges, specialty citrus and other crops that are enjoyed throughout the world. For more about Limoneira Company, visit www.limoneira.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20211027005021/en/

    Get the next $INGN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INGN
    $LMNR
    $MKSI

    CompanyDatePrice TargetRatingAnalyst
    Limoneira Co
    $LMNR
    9/12/2025$18.00Equal-Weight
    Stephens
    MKS Inc.
    $MKSI
    7/10/2025$90.00Sell
    Goldman
    Inogen Inc
    $INGN
    6/16/2025$14.00Buy
    B. Riley Securities
    Limoneira Co
    $LMNR
    6/10/2025$23.00Hold → Buy
    Lake Street
    Inogen Inc
    $INGN
    5/22/2025$12.00Hold → Buy
    Needham
    MKS Inc.
    $MKSI
    5/20/2025$110.00Hold → Buy
    Deutsche Bank
    MKS Inc.
    $MKSI
    1/6/2025$130.00Neutral → Buy
    Citigroup
    MKS Inc.
    $MKSI
    12/13/2024$145.00Overweight
    Analyst
    More analyst ratings

    $INGN
    $LMNR
    $MKSI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stephens resumed coverage on Limoneira with a new price target

    Stephens resumed coverage of Limoneira with a rating of Equal-Weight and set a new price target of $18.00

    9/12/25 7:51:52 AM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    Goldman initiated coverage on MKS Inc. with a new price target

    Goldman initiated coverage of MKS Inc. with a rating of Sell and set a new price target of $90.00

    7/10/25 8:57:27 AM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    B. Riley Securities initiated coverage on Inogen with a new price target

    B. Riley Securities initiated coverage of Inogen with a rating of Buy and set a new price target of $14.00

    6/16/25 7:50:27 AM ET
    $INGN
    Industrial Specialties
    Health Care

    $INGN
    $LMNR
    $MKSI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO & Treasurer Bourque Michael J. was granted 48,225 shares, converted options into 25,000 shares, covered exercise/tax liability with 28,579 shares and bought $24,960 worth of shares (3,000 units at $8.32) (SEC Form 4)

    4 - Inogen Inc (0001294133) (Issuer)

    3/4/25 6:42:36 PM ET
    $INGN
    Industrial Specialties
    Health Care

    CEO and President Smith Kevin Raymond Merrill was granted 55,475 shares, converted options into 28,333 shares, covered exercise/tax liability with 39,797 shares and bought $100,245 worth of shares (11,709 units at $8.56), increasing direct ownership by 383% to 70,274 units (SEC Form 4)

    4 - Inogen Inc (0001294133) (Issuer)

    3/4/25 6:41:11 PM ET
    $INGN
    Industrial Specialties
    Health Care

    Henry David Philip bought $170,862 worth of shares (2,500 units at $68.34), increasing direct ownership by 29% to 11,073 units (SEC Form 4)

    4 - MKS INSTRUMENTS INC (0001049502) (Issuer)

    11/8/23 11:40:45 AM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    $INGN
    $LMNR
    $MKSI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MKS Inc. Reports Third Quarter 2025 Financial Results

    Revenue of $988 million, at the high end of guidance GAAP net income of $74 million and net income per diluted share of $1.10, each in the upper half of guidanceAdjusted EBITDA of $240 million and Non-GAAP net earnings per diluted share of $1.93, each in the upper half of guidanceOperating cash flow of $197 million and free cash flow of $147 million, enabling continued focus on the prepayment of debt and reducing net leverage ratio to 3.9x ANDOVER, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ:MKSI), a global provider of enabling technologies that transform our world, today reported its financial results for the third quarter of 2025. "We executed yet another solid quarter of

    11/5/25 4:30:00 PM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    Inogen Announces Third Quarter 2025 Financial Results

    Delivered seventh consecutive quarter of mid-single-digit revenue growth Reiterating full-year revenue guidance Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2025. Recent Highlights $92.4 million revenue, a year-over-year increase of 4.0%, marking the seventh consecutive quarter of mid-single-digit percentage growth GAAP net loss of $5.3 million and adjusted net loss of $0.5 million compared to prior year GAAP net loss of $6.0 million and adjusted net loss of $2.6 million $2.3 million adjusted EBITDA, the third consecutive quart

    11/5/25 7:30:00 AM ET
    $INGN
    Industrial Specialties
    Health Care

    MKS Inc. Declares Quarterly Cash Dividend

    ANDOVER, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ:MKSI), a global provider of enabling technologies that transform our world, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on December 5, 2025, to shareholders of record as of November 24, 2025.  Future dividend declarations, as well as the record and payment dates for such dividends, are subject to the final determination of the Company's Board of Directors. About MKS Inc.MKS Inc. (NASDAQ:MKSI) enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging,

    11/4/25 9:00:00 AM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    $INGN
    $LMNR
    $MKSI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: President and CEO Edwards Harold S covered exercise/tax liability with 9,811 shares, decreasing direct ownership by 4% to 215,479 units (SEC Form 4)

    4/A - Limoneira CO (0001342423) (Issuer)

    11/7/25 6:07:32 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    Amendment: EVP, CFO and Treasurer Palamountain Mark covered exercise/tax liability with 5,822 shares, decreasing direct ownership by 6% to 94,461 units (SEC Form 4)

    4/A - Limoneira CO (0001342423) (Issuer)

    11/7/25 6:06:11 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    EVP, GC & Secretary Burke Kathleen Flaherty converted options into 777 shares and covered exercise/tax liability with 777 shares (SEC Form 4)

    4 - MKS INC (0001049502) (Issuer)

    11/4/25 5:01:43 PM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    $INGN
    $LMNR
    $MKSI
    SEC Filings

    View All

    SEC Form 10-Q filed by Inogen Inc

    10-Q - Inogen Inc (0001294133) (Filer)

    11/6/25 4:08:33 PM ET
    $INGN
    Industrial Specialties
    Health Care

    SEC Form 10-Q filed by MKS Inc.

    10-Q - MKS INC (0001049502) (Filer)

    11/6/25 2:01:07 PM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    MKS Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - MKS INC (0001049502) (Filer)

    11/5/25 4:31:59 PM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    $INGN
    $LMNR
    $MKSI
    Financials

    Live finance-specific insights

    View All

    MKS Inc. Reports Third Quarter 2025 Financial Results

    Revenue of $988 million, at the high end of guidance GAAP net income of $74 million and net income per diluted share of $1.10, each in the upper half of guidanceAdjusted EBITDA of $240 million and Non-GAAP net earnings per diluted share of $1.93, each in the upper half of guidanceOperating cash flow of $197 million and free cash flow of $147 million, enabling continued focus on the prepayment of debt and reducing net leverage ratio to 3.9x ANDOVER, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ:MKSI), a global provider of enabling technologies that transform our world, today reported its financial results for the third quarter of 2025. "We executed yet another solid quarter of

    11/5/25 4:30:00 PM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    Inogen Announces Third Quarter 2025 Financial Results

    Delivered seventh consecutive quarter of mid-single-digit revenue growth Reiterating full-year revenue guidance Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended September 30, 2025. Recent Highlights $92.4 million revenue, a year-over-year increase of 4.0%, marking the seventh consecutive quarter of mid-single-digit percentage growth GAAP net loss of $5.3 million and adjusted net loss of $0.5 million compared to prior year GAAP net loss of $6.0 million and adjusted net loss of $2.6 million $2.3 million adjusted EBITDA, the third consecutive quart

    11/5/25 7:30:00 AM ET
    $INGN
    Industrial Specialties
    Health Care

    MKS Inc. Declares Quarterly Cash Dividend

    ANDOVER, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- MKS Inc. (NASDAQ:MKSI), a global provider of enabling technologies that transform our world, today announced that its Board of Directors has authorized a quarterly cash dividend of $0.22 per share, payable on December 5, 2025, to shareholders of record as of November 24, 2025.  Future dividend declarations, as well as the record and payment dates for such dividends, are subject to the final determination of the Company's Board of Directors. About MKS Inc.MKS Inc. (NASDAQ:MKSI) enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging,

    11/4/25 9:00:00 AM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    $INGN
    $LMNR
    $MKSI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by MKS Instruments Inc.

    SC 13G/A - MKS INSTRUMENTS INC (0001049502) (Subject)

    11/14/24 1:22:34 PM ET
    $MKSI
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Inogen Inc

    SC 13G/A - Inogen Inc (0001294133) (Subject)

    11/14/24 11:12:09 AM ET
    $INGN
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13G/A filed by Limoneira Co

    SC 13G/A - Limoneira CO (0001342423) (Subject)

    11/7/24 7:32:12 PM ET
    $LMNR
    Farming/Seeds/Milling
    Consumer Staples

    $INGN
    $LMNR
    $MKSI
    Leadership Updates

    Live Leadership Updates

    View All

    Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer

    Inogen, Inc. (Nasdaq: INGN), a leading medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Naga Rameswamy as Chief Technology Officer, effective September 29, 2025. Mr. Rameswamy joins Inogen from Alcon, where he served as the Vice President and Global Head of Digital Health Platforms. "Naga's deep background in digital health and connected device innovation makes him an ideal fit for Inogen as we continue to expand our technology leadership," said Kevin Smith, President and Chief Executive Officer of Inogen, "His ability to integrate software, data, and devices to improve user experiences will be instrume

    9/25/25 4:05:00 PM ET
    $INGN
    Industrial Specialties
    Health Care

    Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

    Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Mira Kirti Sahney to Inogen's Board of Directors, effective January 31, 2025. The company also announced that Tom West, who has served as a director since April 2023, retired as a member of the Board of Directors, effective January 30, 2025. "We are thrilled to welcome Mira Sahney to the Inogen Board. Mira brings considerable management, technical, and operational experience in the medical device field to Inogen," said Elizabeth Mora, Chairperson of the Board. "Mira's appointment will further strengthen Inogen's Board with a

    2/3/25 4:00:00 PM ET
    $INGN
    $MDT
    $MYO
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus

    Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

    MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences," or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of care, announced today the appointment of MK Raheja, Ph.D. as its Executive Vice President, Research and Development, and Brenton Taylor as its Executive Vice President, Operations, effective November 4, 2024. Sight Sciences also announced that Sam Park, its Chief Operating Officer, who oversaw both R&D and Operations, will be retiring from his role at the Company effective November 15, 2024, and will remain available as a con

    11/7/24 4:04:00 PM ET
    $INGN
    $SGHT
    Industrial Specialties
    Health Care
    Medical/Dental Instruments